Addiction: A Treatable Disease
Nathaniel Graham
Addiction: Definitions and Statistics

The Betty Ford Center: A Model for Treatment
The Betty Ford Center (BFC) is a chemical dependency treatment center
located in Southern California. 70% of the staff identifies as in recovery.
Treatment Goals:

Nearly 1 in 7 Americans (~40
million people) are addicted
to a chemical substance.

An additional 2 in 7 Americans (~80
million people) qualify as risky
substance users; those who use
chemical substances in ways that
threaten their health and safety.

Chemical addiction is a chronic disease of the brain causing physical
changes in areas related to reward, motivation, and memory. The
manifestations of those changes include the biological, psychological,
social, and spiritual changes that are commonly associated with
addiction, including the pathological pursuit of a chemical substance.
Risky use is the use of addictive substances in ways that threaten public
health and safety. While this use increases the risk of harm and can
certainly lead to addiction, it does not qualify as addiction.
The Treatment Disconnect:
- Despite the number of people suffering from addiction, there is a
disproportionately low amount of funding spent on addiction treatment
when compared to other common chronic diseases in the U.S.
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- There is a lack of awareness of the issue of addiction. Only 29% of
patients who visited a general practitioner in 2011 reported being
asked about their use of alcohol or recreational drugs.
- No national standards exist defining who may provide addiction
treatment, with only one state requiring a master’s degree, and six
states requiring only a high school diploma.

1.) To remove all non-medical chemicals.
2.) To reteach a lifestyle free of chemical use.

Treatment Methods:
- Detoxification: A licensed detoxification unit is on campus. BFC is also
located next to Eisenhower Medical Center in case of emergencies.
- Chemical Therapy: BFC does not use ongoing chemical treatment for
addiction with any drugs, including Methadone and Suboxone.
- Inpatient: Duration of treatment is ~30 days. Patients have daily small
group therapy sessions, lectures, and exercise periods. Patients sleep
dorm-style and must remain on campus at all times. They are not
permitted use of cell phones or computers. The 12-step recovery model
is heavily used.
- Outpatient: Duration of treatment is ~60 days. Patients have daily small
group therapy sessions, lectures, and exercise periods. Patients
transition to normal life by living in community residential housing
owned by BFC and having access to cell phones and computers. Cars are
only allowed with special permission and are not to be driven alone.

The Biology of Addiction
Anatomy:
Nearly all drugs of abuse affect the
mesolimbic reward system of the
brain. This pathway extends from the
ventral tegmental area to the nucleus
accumbens. It eventually connects to
the prefrontal cortex, which is where
decision-making takes place in the
brain.
Acute drug use modifies brain function in ways that provide the
characteristic “high”.
Prolonged drug use causes physical changes to the mesolimbic reward
system that persist when the drug of abuse is no longer being taken. These
physical changes affect normal processes that include:
- Brain metabolic activity
- Neurotransmitter receptor availability
- Gene expression
- Responsiveness to environmental cues

Treating the Addicted Physician
The Bad News:
10-12% of doctors are addicted to a chemical substance.
This rate is consistent with the percentage of the general population who are
addicted to a chemical substance. Certain medical specialties have higher
rates of addiction, including anesthesiologists, emergency medicine
physicians, and psychiatrists.
The Good News:
74-90% of doctors who undergo treatment will remain chemical free.
This rate is much higher than the percentage of the general population who
remain abstinent. One explanation for the difference is that the licensing
board for physicians require longer durations of treatment and monitoring
than is made available to the general population. This suggests that longer
durations of treatment result in greater abstinence.
Protection for the Addicted Physician:
Most state licensing boards have shown leniency on physicians who come
forward with addiction issues and who are willing to engage in treatment.
This promotes the health and well-being of physicians and also protects the
patients they treat. In addition, several laws including the Americans with
Disabilities Act, provide general employment protection to physicians who
are either actively engaged in treatment for a chemical addiction, or who
are recovering addicts.
Treatment for the Addicted Physician:
Physicians with a chemical addiction must meet several requirements to keep
their medical licenses. These requirements vary by state, but may include:
- Completion of an inpatient treatment program
- Continuing outpatient treatment (~ 5 years)
- Periodic drug testing/monitoring (~ 5 years)
- Use of Naloxone (opioid antagonist)
Where to Seek Help:
- State Physician Health Programs (PHP) - Programs designed to manage the
ongoing drug monitoring for physicians in recovery.
- International Doctors in Alcoholics Anon. - A membership only branch of AA
requiring proof of doctorate level education in a health field. All meetings and
member names are kept confidential. (www.IDAA.org)
- Alcoholics Anonymous - AA offers meetings specifically for healthcare workers of
all types, including caduceus meetings. (www.AA.org)

References
1. Berge, K.H., Seppala, M.D., Agnes, M.S. Chemical Dependency and the Physician. Mayo Clinic Proc. July 2009; 84(7): 625-631.
2. Lane, J.B., Califano, Jr., J.A., et al. Addiction Medicine: Closing the Gap between Science and Practice. National Center on
Addiction and Substance Abuse at Columbia University. June 2012.
3.Leshner, Alan I. Addiction Is a Brain Disease, and It Matters, Science. 3 October 1997: Vol.278. no. 5335, pp.45-457.
4.Yancey, J.R., and McKinnon, Jr., H.D., Reaching Out to an Impaired Physician. Family Practice Management. 2010 Jan-Feb;17(1):
27-31.

